Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Chu, Chung et al. quantify the clinical utility of genome sequencing (GS) using the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) in a diverse cohort from the Hong Kong Genome Project.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results